Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05602636
Other study ID # IRB 00012367-22-011-003
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date December 10, 2022
Est. completion date April 30, 2024

Study information

Verified date February 2024
Source Al-Azhar University
Contact Neveen A. Kohaf, Ph.D
Phone +201069482380
Email nevenabdo@azhar.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The etiology of tourniquet pain is complex, and the study team hypothesizes that blocking with Interscalene brachial plexus block (ISBPB) is more efficient in decreasing the incidence of tourniquet pain in comparison with other techniques. As there is a paucity of studies that evaluate the effect of intercostobrachial nerve (ICBN) block and ISBPB and Patient-Controlled Analgesia (PCA) with a supraclavicular brachial plexus block (SCBPB) on tourniquet pain in forearm surgery, Therefore, we established this randomized study to compare ISBPB and ICBN and PCA with fentanyl with SCBPB in terms of the incidence and severity of tourniquet pain in patients undergoing forearm surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date April 30, 2024
Est. primary completion date April 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - aged more than 18 years, - ASAI-III patients - scheduled to undergo orthopedic or plastic surgery distal to the elbow with an anticipated tourniquet duration greater than 45 min. - desiring regional anesthesia as the primary anesthetic. Exclusion Criteria: - Contraindication to regional anesthesia. - Allergy to local anesthetics. - Primary block failure. - If patients desired deep intraoperative sedation. - Clinically significant cognitive impairment.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
bupivacaine, midazolam
Patients will be provided with midazolam (up to 2 mg) if requested. No opioids will be administered before the incision. At the first patient complaint of pain, the intraoperative anesthesia team will document the quality and location of pain, and 50 microgram of fentanyl will be administered if the patient requested it or pain score more than 3

Locations

Country Name City State
Egypt Facualty of Medicine(Damietta), Al Azhar University Damietta

Sponsors (1)

Lead Sponsor Collaborator
Al-Azhar University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of tourniquet pain The incidence of tourniquet pain will be assessed by the patient's VAS score. The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). The patient is asked to rate their current level of pain by placing a mark on the line. 2 hours
Secondary Hemodynamics Hemodynamics up to 2 hours postoperative (heart rate, mean arterial blood pressure. Mean arterial blood pressure and heart rate will be recorded at baseline and every 5 min till the end of the procedure. 2 hours
Secondary The incidence of adverse reactions The incidence of adverse reactions (Pneumothorax, Horner's syndrome) will be evaluated. 2 hours
Secondary Patients' satisfaction Patients' satisfaction will be measured immediately postoperative and after 24 hours using a five-point Likert scale consisting of "very dissatisfied," "dissatisfied," "unsure," "satisfied," and "very satisfied. 24 hours
See also
  Status Clinical Trial Phase
Completed NCT02714738 - Infraclavicular Block: Decreased Incidence of Tourniquet Pain, Compared to Axillary Brachial Plexus Block? N/A
Not yet recruiting NCT03357055 - Ketamine Reduces Tourniquet Pain In Patients Undergoing Lower Limb Surgery Under Spinal Anaesthesia Phase 4
Completed NCT05342870 - A Sequential Allocation Study to Determine the ED50 of Dexmetedomidine as an Adjuvant to Lidocaine Intravenous Regional Anesthesia N/A